M Anthony

Summary

Affiliation: The Critical Path Institute
Country: USA

Publications

  1. doi request reprint Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium
    M Anthony
    The Critical Path Institute, Tucson, Arizona, USA
    Clin Pharmacol Ther 86:425-9. 2009
  2. doi request reprint The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases
    K Romero
    Coalition Against Major Diseases, Critical Path Institute, Tucson, Arizona, USA
    Clin Pharmacol Ther 86:365-7. 2009

Collaborators

Detail Information

Publications2

  1. doi request reprint Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium
    M Anthony
    The Critical Path Institute, Tucson, Arizona, USA
    Clin Pharmacol Ther 86:425-9. 2009
    ..This study provides evidence that there is little concordance among commonly used drug compendia and product labels with respect to interactions involving warfarin...
  2. doi request reprint The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases
    K Romero
    Coalition Against Major Diseases, Critical Path Institute, Tucson, Arizona, USA
    Clin Pharmacol Ther 86:365-7. 2009
    ..The coalition's purpose is to transform the drug development paradigm for neurodegenerative diseases and serve as a model for other major diseases...